Navigation Links
Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
Date:3/26/2008

FREMONT, Calif., March 26 /PRNewswire/ -- Breathe Technologies, Inc., which is developing innovative, patient-friendly medical devices to treat respiratory problems associated with Chronic Obstructive Pulmonary Disease (COPD), cystic fibrosis, and influenza announced today that it has closed on $15 million in its second round of venture funding. The investment was led by Kleiner Perkins Caufield & Byers (KPCB) with participation from existing venture investors, including Synergy Partners International, Delphi Ventures and Life Science Angels.

"Breathe Technologies is developing unique, transformational technologies for patients with emphysema, chronic bronchitis and other respiratory ailments," said KPCB partner Beth Seidenberg, M.D., who joined the company's board of directors and was also formerly the Chief Medical Officer of Amgen. "More broadly, innovation in ventilator technology is crucial to help prepare our nation for potential pandemics such as influenza or other infectious agents. We believe Breathe Technologies has the potential to address these significant unmet needs."

Breathe Technologies is developing a unique family of compact, ultra-lightweight, ambulatory respiratory ventilator systems for the hospital, homecare and pandemic markets. Annual worldwide sales of conventional respiratory systems that the company's products could enhance or replace are estimated at more than $2 billion.

"Our goal is to improve the quality of life for people suffering from breathing disorders while reducing the high mortality rates associated with respiratory diseases," said Gregory J. Kapust, President and CEO of the company. "KPCB has a remarkable track record of partnering with companies that change industries and reshape markets. Our vision is to become the first provider of ultra-lightweight, truly patient-friendly ventilator systems that can transform respiratory care in the hospital and home."

Breathe Technologies, Inc., is locat
'/>"/>

SOURCE Breathe Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Leading Health Groups Strongly Support the Minnesota Department of Healths Efforts to Enforce Freedom to Breathe Act
2. Breathe Easy. Play Hard.
3. BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivors Perspective
4. BODY WORLDS 2 & Breathe California Pair Up for Some Ash Kicking
5. BREATHE Lung Cancer Conference, Nov. 30, Attracts World Renowned Physicians and Speakers
6. Hundreds to Gather for Rally in Celebration of Right to Breathe Clean Air
7. Accordions Breathe Easier Since Smoking Ban
8. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
9. Vital Health Technologies, Inc. / Caribbean American Health Resorts Inc. Acquires Momentum Medical Group, Inc.
10. Sandata Technologies, Inc. Adds TeleTimecard to its Service Offering
11. China Display Technologies, Inc. to Present at Roth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Dennis Thompson HealthDay ... -- An experimental antibody drug could prove effective at ... side effects with cholesterol-lowering statin medications. That,s the ... American Heart Association annual meeting in Chicago. The ... the most widely used alternative to statins, Zetia, said ...
(Date:11/18/2014)... November 18, 2014 Financing for ... on innovative financing for international development, has announced ... Membership includes six Directors: Mr. John Skibiak of ... of the Millennium Challenge Corporation, Mr. Pape Gaye ... Impact Advisors, Mr. Aron Betru of Financing for ...
(Date:11/18/2014)... A+ Secure Packaging, a leading ... supplements and more, announced today that its LaVergne ... Practices (GMP) Registration for dietary supplements and athletic ... International verifies the A+ Secure Packaging facility meets ... of its clients by demonstrating the proper methods, ...
(Date:11/18/2014)... News) -- Hispanic women who,ve had at least five children ... heart trouble than those who,ve had fewer children or none, ... by Shivani Aggarwal of Wake Forest School of Medicine analyzed ... Miami, New York City and San Diego. About 12 percent ... A type of heart trouble called ventricular diastolic dysfunction ...
(Date:11/18/2014)... MONDAY, Nov. 17, 2014 (HealthDay News) -- Until recently, insect-transmitted ... America, but it has made its way to the United ... fatal illness is typically transmitted via the bite of the ... night. And now a new study suggests that common bedbugs ... bedbug can acquire and transmit the parasite. Our next step ...
Breaking Medicine News(10 mins):Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Financing for Development Corp. (F4D) Announces Board of Directors 2Health News:Financing for Development Corp. (F4D) Announces Board of Directors 3Health News:Financing for Development Corp. (F4D) Announces Board of Directors 4Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3
... MONTREAL, Sept. 21 Presagia, provider of ... announced the release of its ADA Toolkit, which will ... FMLA (Family and Medical Leave Act) and ADA (Americans ... supplement Presagia,s Leave Management solution, which enables customers to ...
... For the past 18 months, Atlantic has been partnering ... and production of a hands-on, interactive exhibit to be installed ... create an interactive environment that would reduce the anxiety of ... James Morris, Director of Business Development. "At the onset, I ...
... , SANTA ROSA, Calif., Sept. 21 Osseon ... cement delivery needle) and Osseoflex DR (steerable and curvable bone ... for marketing and clinical use in the European Union. , ... FDA approval in the United States, and allows for the ...
... , , , ... US, Inc. ("Astellas"), in partnership with the National Science Teachers ... Chicago-area science teachers to participate in the 2009 NSTA New ... teachers to a range of tools and resources, while providing ...
... The Defense Advanced Research Projects Agency (DARPA), the research arm ... $19.5 million for an effort led by the Duke Institute ... easy-to-use diagnostic device that can reveal who is infected with ... DARPA is interested in such a device because ...
... that individuals use a variety of cues to identify their ... than their own. A new study shows that their success ... families are the same race as themselves. In ... ("Cross-cultural perceptions of facial resemblance between kin"), French and ...
Cached Medicine News:Health News:Presagia Solution Helps Employers Navigate Overlapping ADA and FMLA Regulations 2Health News:Presagia Solution Helps Employers Navigate Overlapping ADA and FMLA Regulations 3Health News:Atlantic Partners with Children's Hospital of Philadelphia to Create an Interactive & Educational Waiting Room 2Health News:Osseon Receives CE Mark 2Health News:Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 2Health News:Astellas and The National Science Teachers Association Announce 2009 Class of Local Science Educators 3Health News:DARPA awards Duke $19.5 million to detect viral infection before symptoms appear 2Health News:Race has little effect on people's ability to spot family resemblances 2
(Date:11/17/2014)... -- AbbVie (NYSE: ABBV ) will participate in the ... on Thursday, Nov. 20, 2014. Bill Chase , ... formal presentation on the company at 9:20 a.m. GMT (3:20 ... of the presentation will be accessible through AbbVie,s Investor Relations ... the session will be available later that day. ...
(Date:11/17/2014)... , Nov. 17, 2014   Wilson Therapeutics ... start of a Phase 2 clinical study to evaluate ... in Wilson Disease, a rare genetic disorder and designated ... process copper. "We are delighted to proceed ... as a next step in the development program for ...
(Date:11/16/2014)...  Hanger, Inc. (NYSE: HGR ) announced ... third quarter 2014 financial results and is cancelling its ... for the completion and review of its third quarter ... financial results and reschedule its conference call after the ... About Hanger, Inc. – Built on the ...
Breaking Medicine Technology:Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3
... , SINGAPORE, Dec. 15 ... it has completed the previously announced acquisition of SloMedical ... ranging from tubing sets to complex devices for minimally-invasive ... set of capabilities to medical device, medical equipment, and ...
... Open enrollment is an opportune time to find the best ... 15 Through the end of the year, thousands of Nebraska ... This is when the state,s 268,000 Medicare beneficiaries get to ... in 2010. , Prescription drug coverage is a critical part ...
Cached Medicine Technology:Flextronics Completes SloMedical Acquisition 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2
Shandon Plastic Slide Boxes...
Shandon Cardboard Slide Folders...
... The new Propaq LT is the ... environment--combining the basic parameters of continuous vital ... new design, making it perfect for just ... place. , Light enough to clip on ...
Exxcel Soft ePTFE vascular graft, designed for exceptional kink resistance and crush resistance, maintains a Soft touch for easier handling during peripheral vascular bypass procedures and vascular a...
Medicine Products: